DOI: 10.1055/s-00023610

Drug Research

References

Macha S, Rose P, Mattheus M. et al.
Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose cotransporter 2 inhibitor, in patients with hepatic impairment.

Diabetes Obes Metab 2014;
16: 118-123

Download Bibliographical Data

Access: